Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-34
Closed -$2.57K 1460
2026
Q1
$2.57K Hold
34
﹤0.01% 867
2025
Q4
$2.53K Hold
34
﹤0.01% 806
2025
Q3
$2.29K Hold
34
﹤0.01% 791
2025
Q2
$2.22K Hold
34
﹤0.01% 732
2025
Q1
$2.1K Sell
34
-29
-46% -$1.92K ﹤0.01% 694
2024
Q4
$4.54K Hold
63
﹤0.01% 549
2024
Q3
$5.13K Buy
63
+29
+85% +$2.32K ﹤0.01% 546
2024
Q2
$2.52K Hold
34
﹤0.01% 622
2024
Q1
$2.65K Hold
34
﹤0.01% 641
2023
Q4
$2.43K Hold
34
﹤0.01% 631
2023
Q3
$2.36K Sell
34
-10
-23% -$756 ﹤0.01% 596
2023
Q2
$3.56K Buy
44
+10
+29% +$817 ﹤0.01% 560
2023
Q1
$2.74K Hold
34
﹤0.01% 540
2022
Q4
$2.54K Sell
34
-52
-60% -$3.7K ﹤0.01% 499
2022
Q3
$5.55K Buy
+86
New +$5.96K ﹤0.01% 352

Other funds holding HOLX

Abound Wealth Management's HOLX Position: Q2 2026 in Review

Abound Wealth Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 34 shares — an estimated $2.57K sold.

Abound Wealth Management first reported a position in HOLX in Q3 2022 and held it in 15 quarters. The position peaked at $5.55K in Q3 2022. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Abound Wealth Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Abound Wealth Management sold 34 Hologic shares in Q2 2026, an estimated $2.57K.
  • Abound Wealth Management first reported a position in Hologic in Q3 2022 and held it in 15 quarters.
  • Abound Wealth Management's Hologic position peaked at $5.55K in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.